Reissue of RFA-FD-22-001 - Efficient and Innovative Natural History Studies Addressing Unmet Needs in Rare Diseases (R01 Clinical Trials Optional)
Reissue of RFA-FD-22-001 - Efficient and Innovative Natural History Studies Addressing Unmet Needs in Rare Diseases (R01 Clinical Trials Optional) is offered by Food and Drug Administration. Max award: $600,000. Applications close on Feb 8, 2028.
| Opportunity number | RFA-FD-25-017 |
|---|---|
| Agency | Food and Drug Administration |
| Status | Posted |
| Posted | Jul 11, 2025 |
| Closes | Feb 8, 2028 |
| Award ceiling | $600,000 |
| Award floor | Not specified |
| Total program funding | Not specified |
| Expected awards | Not specified |
| Who can apply | Others (see text field entitled "Additional Information on Eligibility" for clarification) |
| Category | Agriculture, Consumer Protection, Food and Nutrition |
Summary (excerpt)
The purpose of this notice of funding opportunity (NOFO) is to support efficient and innovative natural history studies that advance medical product development in rare diseases/conditions with unmet needs. Through the support of natural history studies with high quality and interpretable data elements, FDA expects to address critical knowledge gaps, remove major barriers to progress in the field, exert a significant and broad impact on a specifi…
View the official listing and apply on Grants.gov
Before you apply
- Register your organization in SAM.gov and get a UEI — it can take weeks
- Create a Grants.gov account and check eligibility in the full notice (NOFO)
- Start early; the system gets busy near deadlines
Grants closing soon · More from Food and Drug Administration